[Secondary prevention after myocardial infarct].

[Myocardial rupture after myocardial infarct].

General aspects of secondary prevention after myocardial infarction.

Secondary prevention with calcium antagonists after acute myocardial infarction.

[Fitness for swimming after myocardial infarct].

Myocardial infarct imaging after cardiac surgery.

[The diagnosis after an acute myocardial infarct].

Myocardial infarction. Secondary prevention with nifedipine.

Stroke after acute myocardial infarction: relation to infarct size.

[Long-term therapy after an acute myocardial infarct].

Adenosine diphosphate reduces infarct size and improves porcine heart function after myocardial infarct.

Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus.

Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.

Secondary prevention after myocardial infarction: it takes two (physician and patient) to tango.

Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.

Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.

Rapid mobilisation after acute myocardial infarction. First step in rehabilitation and secondary prevention.

Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade.

Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance.

Secondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 year.

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.

[Myocardial infarct and ovulation inhibitors].

Aspirin and secondary mortality after myocardial infarction.

Medication adherence in secondary prevention post-myocardial infarction.

Suggest Documents

[Myocardial rupture after myocardial infarct].

General aspects of secondary prevention after myocardial infarction.

Secondary prevention with calcium antagonists after acute myocardial infarction.

[Fitness for swimming after myocardial infarct].

Myocardial infarct imaging after cardiac surgery.

[The diagnosis after an acute myocardial infarct].

Myocardial infarction. Secondary prevention with nifedipine.

Stroke after acute myocardial infarction: relation to infarct size.

[Long-term therapy after an acute myocardial infarct].

Adenosine diphosphate reduces infarct size and improves porcine heart function after myocardial infarct.

Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus.

Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.

Secondary prevention after myocardial infarction: it takes two (physician and patient) to tango.

Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.

Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.

Rapid mobilisation after acute myocardial infarction. First step in rehabilitation and secondary prevention.

Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade.

Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance.

Secondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 year.

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.

[Myocardial infarct and ovulation inhibitors].

Aspirin and secondary mortality after myocardial infarction.

Medication adherence in secondary prevention post-myocardial infarction.

[Secondary prevention after myocardial infarct].

Recommend Documents

Follow Us